How to Calculate PSA Density
For men over age 50, the best means to screen for prostate cancer require a combination of tests: the prostate specific antigen blood test and a digital rectum scan, according to Dr. Michael Cookson of the Department of Urological Surgery at Vanderbilt University Medical School. The numbers from a PSA test can return a false positive for cancer, which often occurs in men with benignly enlarged prostate glands, notes the University of Pennsylvania's Abramson Cancer Center. Relating the results of a PSA test to the size of a man's prostate can help doctors to determine whether the higher level of PSA results from a benign enlargement or from cancer. To find this number, an accurate volume of the prostate gland must be made using a transrectal ultrasound, which can make finding the PSA density expensive, according to John's Hopkins. Dr. Michael Cookson notes that the results of a PSA density might show a false positive or negative for cancer, as the PSA test results vary daily and the accuracy of TRUS for finding prostate volume does not produce accurate results.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Look at the PSA test results to determine whether the patient needs a transrectal ultrasound to find the size used in calculating PSA density. Opt for a TRUS if the PSA test returns results of 2.5 ng/ml or higher. The University of Pennsylvania notes that some researchers recommend a biopsy or additional testing, while others continue tests at levels of 4.0 ng/ml to 10 ng/ml for the PSA test.
What Are the Causes of Breast Density?
Learn More
Conduct a transrectal ultrasound to find the prostate volume by measuring the length, width and height of the prostate. Multiply these numbers together and multiply the result by 0.52 to find the prostate volume.
Divide the PSA test number by the size of the prostate gland found during the transrectal ultrasound to find the PSA density. For instance, if a patient has a PSA test of 6.0 ng/ml and a prostate volume of 40 ml, divide 6.0 by 40.
6.0/40 = 0.15.
What Food or Drink Can Raise Your PSA Levels?
Learn More
Evaluate the results of the PSA density for numbers of 0.15 or higher, lessening the likelihood that the elevated PSA test came from a benign growth, according to Cookson. Consider either a “watch and wait” approach or biopsy for further evaluation of the patient's health.
Related Articles
References
- National Cancer Institute. Prostate Cancer Screening (PDQ®)–Patient Version. Updated April 10, 2019.
- Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;319(18):1914-1931. doi:10.1001/jama.2018.3712
- American Cancer Society. If Prostate Cancer Screening Test Results Aren’t Normal. Updated April 14, 2016.
- American Cancer Society. Understanding Your Pathology Report: Prostate Cancer. Updated March 8, 2017.
- Axumin. Prescribing information. Updated May 2016.
- National Cancer Institute. Genetics of Prostate Cancer (PDQ®)–Health Professional Version. Updated October 4, 2019.
- American Cancer Society. Prostate Cancer Stages and Other Ways to Assess Risk. Updated August 1, 2019.
- National Comprehensive Cancer Network. NCCN Guidelines for Patients: Prostate Cancer. 2018.
- American Cancer Society. Following PSA Levels During and After Prostate Cancer Treatment. Updated August 1, 2019.
- Penn State Health. Milton S. Hershey Medical Center. Conditions with Similar Symptoms as: Prostate Cancer.
- American Society of Clinical Oncology. Prostate Cancer: Diagnosis. Updated 03/2018. www.cancer.net/cancer-types/prostate-cancer/diagnosis
- Fenton, J., Weyrich, M., Durbin, S., Liu, Y., Bang, H., and J. Melnikow. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018. 319(18):1914-1931.
- Filella, X., Fernandez-Galan, E., Fernandez-Bonifacio, R., and L. Foi. Emerging Biomarkers in the Diagnosis of Prostate Cancer. Pharmgenomics and Personalized Medicine. 2018. 11:83-94.
- Li, Q., Xiang, F., Lin, X. et al. The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along 10 Imaging Touch Points. Urology. 2018 May 3. (Epub ahead of print).
- National Cancer Institute. Prostate Cancer Screening (PDQ)—Health Professional Version. Updated 02/22/18. www.cancer.gov/types/prostate/hp/prostate-screening-pdq#section/_1
- Sources:
- Buyyoumouski, M., Choyke, P., McKenney, J. et al. Prostate Cancer: Major Changes in the American Joint Committee on Cancer Eight Edition Cancer Staging Manual. CA: A Cancer Journal for Clinicians. 2017. 67(3):245-253.